Now available SUSVIMO™ (ranibizumab injection) Implant with insertion tool

SUSVIMO (ranibizumab injection) for intravitreal use via SUSVIMO ocular implant, is a vascular endothelial growth factor (VEGF) inhibitor indicated for the treatment of patients with Neovascular (wet) Age-related Macular Degeneration (AMD) who have previously responded to at least two intravitreal injections of a VEGF inhibitor.

View full prescribing information.